Table 1 |
|||||
|
Characteristics of persons diagnosed with AIDS in San Francisco, 1996–2006, by housing status at diagnosis (N = 6558) |
|||||
|
Characteristics |
Homeless |
Non-Homeless |
|||
|
|
|||||
|
(N = 641) |
(N = 5917) |
||||
|
|
|||||
|
N |
% |
N |
% |
P value* |
|
|
|
|||||
|
Gender |
<0.0001 |
||||
|
|
|||||
|
Male |
497 |
77.54 |
5363 |
90.64 |
|
|
|
|||||
|
Female |
94 |
14.66 |
399 |
6.74 |
|
|
|
|||||
|
Transgender |
50 |
7.80 |
155 |
2.62 |
|
|
|
|||||
|
|
|||||
|
Age at diagnosis (years) |
0.0003 |
||||
|
|
|||||
|
13–29 |
83 |
12.95 |
539 |
9.11 |
|
|
|
|||||
|
30–39 |
255 |
39.78 |
2361 |
39.90 |
|
|
|
|||||
|
40–49 |
229 |
35.73 |
2032 |
34.34 |
|
|
|
|||||
|
50+ |
74 |
11.54 |
985 |
16.65 |
|
|
|
|||||
|
|
|||||
|
Race/ethnicity |
<0.0001 |
||||
|
|
|||||
|
White |
260 |
40.56 |
3646 |
61.62 |
|
|
|
|||||
|
African American |
252 |
39.31 |
963 |
16.28 |
|
|
|
|||||
|
Latino |
106 |
16.54 |
944 |
15.95 |
|
|
|
|||||
|
Asian/Pacific Islander/Native American/Other |
23 |
3.59 |
364 |
6.15 |
|
|
|
|||||
|
|
|||||
|
Risk group |
<0.0001 |
||||
|
|
|||||
|
Men who have sex with men |
135 |
21.06 |
4098 |
69.26 |
|
|
|
|||||
|
Injection drug user |
257 |
40.09 |
634 |
10.71 |
|
|
|
|||||
|
Men who have sex with men and inject drugs |
213 |
33.23 |
881 |
14.89 |
|
|
|
|||||
|
Heterosexual/Other |
36 |
5.62 |
304 |
5.14 |
|
|
|
|||||
|
|
|||||
|
Insurance status |
<0.0001 |
||||
|
|
|||||
|
Public |
212 |
33.07 |
1205 |
20.37 |
|
|
|
|||||
|
Private |
7 |
1.09 |
2628 |
44.41 |
|
|
|
|||||
|
None |
408 |
63.65 |
1906 |
32.21 |
|
|
|
|||||
|
Unknown |
14 |
2.18 |
178 |
3.01 |
|
|
|
|||||
|
|
|||||
|
Initial AIDS diagnosis |
0.3518 |
||||
|
|
|||||
|
CD4 count <200 cells/mm3 |
503 |
78.47 |
4735 |
80.02 |
|
|
|
|||||
|
Opportunistic illness |
138 |
21.53 |
1182 |
19.98 |
|
|
|
|||||
|
|
|||||
|
CD4 count at diagnosis (mean cells/mm3)† |
172 |
184 |
0.0346 |
||
|
|
|||||
|
|
|||||
|
Ever received highly active antiretroviral therapy |
<0.0001 |
||||
|
|
|||||
|
Yes |
454 |
70.83 |
4870 |
82.31 |
|
|
|
|||||
|
No |
187 |
29.17 |
1047 |
17.69 |
|
|
|
|||||
|
|
|||||
|
Ever received prophylaxis against Pneumocystis jirovecii pneumonia |
|||||
|
|
|||||
|
Yes |
417 |
65.05 |
3384 |
57.19 |
0.0001 |
|
|
|||||
|
No |
224 |
34.95 |
2533 |
42.81 |
|
|
|
|||||
|
|
|||||
|
Ever received prophylaxis against Mycobacterium avium complex |
|||||
|
|
|||||
|
Yes |
173 |
26.99 |
1099 |
18.57 |
<0.0001 |
|
|
|||||
|
No |
468 |
73.01 |
4818 |
81.43 |
|
|
|
|||||
|
* Chi square test for differences in proportions and t test for differences in means. † Excludes 205 cases that were missing CD4 results. |
|||||
|
Schwarcz et al. BMC Public Health 2009 9:220 doi:10.1186/1471-2458-9-220 |
|||||